Intra Cellular Therapies shares owned by Oppenheimer Asset Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Oppenheimer Asset Management
from 13F filings
Historical chart of Oppenheimer Asset Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Oppenheimer Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Oppenheimer Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.4M | 40k | 83.52 |
| 2024-09-30 | $2.8M | 39k | 73.17 |
| 2024-06-30 | $2.4M | 36k | 68.49 |
| 2024-03-31 | $2.0M | 29k | 69.20 |
| 2023-09-30 | $1.8M | 34k | 52.09 |
| 2023-06-30 | $2.0M | 32k | 63.32 |
| 2023-03-31 | $1.8M | 34k | 54.15 |
| 2022-12-31 | $1.6M | 29k | 52.92 |
| 2022-09-30 | $1.4M | 31k | 46.56 |
| 2022-06-30 | $1.1M | 19k | 57.06 |
| 2022-03-31 | $1.5M | 24k | 61.20 |
| 2021-12-31 | $970k | 19k | 51.95 |
| 2021-09-30 | $598k | 16k | 37.31 |
More positions owned by Oppenheimer Asset Management
View all positions for Oppenheimer Asset Management
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies